Dong Lyu
Director/Board Member at GENOR BIOPHARMA HOLDINGS LIMITED
Profile
Dong Lyu is currently a Non-Executive Director at Luye Pharma Group Ltd., Genor Biopharma Holdings Ltd., and a Managing Director at Zhuhai Hillhouse Investment Management Holding Co. Ltd.
and Zhuhai Gao Ling Equity Investment Management Co. Ltd.
He previously held positions as a Director at Shanghai Ark Biopharmaceutical Co., Ltd., Non-Executive Director at Keymed Biosciences, Inc., Jacobio Pharmaceuticals Group Co., Ltd., and Clover Biopharmaceuticals Ltd.
He was also a Managing Director at Pag Growth Zhuhai Holding Investment Management Co. Ltd.
and VP- Pharmaceutical & Medical Device Investment at Shanghai Panxin Equity Investment Management Co. Ltd.
Dr. Lyu received his undergraduate degree from Beijing Medical University, his graduate degree from Peking University, and his doctorate from China Pharmaceutical University.
Dong Lyu active positions
| Companies | Position | Start |
|---|---|---|
| GENOR BIOPHARMA HOLDINGS LIMITED | Director/Board Member | 2021-11-01 |
| LUYE PHARMA GROUP LTD. | Director/Board Member | 2023-12-05 |
| Zhuhai Hillhouse Investment Management Holding Co. Ltd. | Corporate Officer/Principal | 2020-09-29 |
| Zhuhai Gao Ling Equity Investment Management Co. Ltd. | Corporate Officer/Principal | 2020-08-31 |
Former positions of Dong Lyu
| Companies | Position | End |
|---|---|---|
| JACOBIO PHARMACEUTICALS GROUP CO., LTD. | Director/Board Member | 2023-08-30 |
| CLOVER BIOPHARMACEUTICALS, LTD. | Director/Board Member | 2022-10-27 |
| KEYMED BIOSCIENCES INC. | Director/Board Member | 2022-03-28 |
| Pag Growth Zhuhai Holding Investment Management Co. Ltd. | Corporate Officer/Principal | 2020-08-31 |
| Shanghai Panxin Equity Investment Management Co. Ltd. | Corporate Officer/Principal | 2016-06-30 |
Training of Dong Lyu
| Beijing Medical University | Undergraduate Degree |
| China Pharmaceutical University | Doctorate Degree |
| Peking University | Graduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 5 |
|---|---|
| KEYMED BIOSCIENCES INC. | Health Technology |
| JACOBIO PHARMACEUTICALS GROUP CO., LTD. | Health Technology |
| CLOVER BIOPHARMACEUTICALS, LTD. | Health Technology |
| GENOR BIOPHARMA HOLDINGS LIMITED | Health Technology |
| LUYE PHARMA GROUP LTD. | Health Technology |
| Private companies | 5 |
|---|---|
| Shanghai Panxin Equity Investment Management Co. Ltd. | |
| Pag Growth Zhuhai Holding Investment Management Co. Ltd. | |
| Zhuhai Hillhouse Investment Management Holding Co. Ltd. | |
Shanghai Ark Biopharmaceutical Co., Ltd.
 Shanghai Ark Biopharmaceutical Co., Ltd. Pharmaceuticals: MajorHealth Technology Shanghai Ark Biopharmaceutical Co., Ltd. engages in biopharmaceutical services. It is a biopharmaceutical company which focuses on the discovery and development of novel therapeutics addressing unmet medical needs in respiratory and lung diseases. The firm’s product portfolio covering full disease cycle and patient segmentations, its drug candidates addresses a spectrum of acute and chronic respiratory and lung diseases. The company was founded by Jim Zhen WU and Wu Zheng Bo in April 2014 and is headquartered in Shanghai, China. | Health Technology |
| Zhuhai Gao Ling Equity Investment Management Co. Ltd. |
- Stock Market
- Insiders
- Dong Lyu
